Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Testing revenue109.54M94.54%
Product revenue3.19M2.75%
Biopharmaceutical and other revenue3.14M2.71%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States334.53M92.65%
International26.53M7.35%